Background
Financial interactions between pharmaceutical companies and physicians
can lead to conflicts of interest, potentially biasing physicians’
clinical practice. This study examines the extent and trends of
non-research payments made by pharmaceutical companies to
board-certified allergists in Japan between 2016 and 2020.